Stage II disease, elderly patients, secondary neoplasms, and the MOSAIC trial
- PMID: 23509316
- DOI: 10.1200/JCO.2012.47.1854
Stage II disease, elderly patients, secondary neoplasms, and the MOSAIC trial
Comment on
-
Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.J Clin Oncol. 2012 Sep 20;30(27):3353-60. doi: 10.1200/JCO.2012.42.5645. Epub 2012 Aug 20. J Clin Oncol. 2012. PMID: 22915656
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources